M/s Kilitch Drugs (India) ltd was incorporated on 12th May, 1992 with the Registrar of Companies, Maharashtra at Bombay as a public limited company and obtained certificate for commencement of business dated 26-05-92. The company went Public in February 1994 for setting up a pharmaceutical formulation plant to manufacture pharmaceutical products in the form of tablets, capsules, liquid orals, ointments, creams and injectables. The company could not commence its manufacturing activities as planned in the Public Issue on account of delay in completion of building. Till date, the company has not commenced any manufacturing activities. The land and building is now completed and in order to have the benefit of its capacity, the company is planning this rights issue for expanding its injectable capacity from 30,000 ltrs. to 75,000 Itrs. Due to delay in implementation of project, the company could not come out with its own production till date and therefore the company is presently trading in pharmaceutical formulations like tablets, capsules, liquid orals, ointments, creams and injectables. The trading turnover of the company for the year 1994-95 was Rs.550.50 Lacs. 2008 -Board recommends final dividend of 10%. 2009 -The Company got a GOLD AWARD for Quality Excellence. 2010 -Listing of Equity Shares at NSE. 2011 2015 -Kilitch Drugs entered joint venture with local firm in Ethopia 2021 -Kilitch Drugs starts production of Cephalosporins Injectables at Ethiopia Plant' dated 26th July 2021. 2025 -The company issued rights shares of Rs. 10 in the ratio of 2:23 at a premium of Rs. 347 per share.